We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Committees Approve Tysabri for Crohn's Disease
FDA Advisory Committees Approve Tysabri for Crohn's Disease
August 3, 2007
Biogen Idec and Elan’s multiple sclerosis drug Tysabri has received a green light for use in the treatment of Crohn’s disease.